We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
UK approves Vyjuvek gene gel for wound treatment in dystrophic epidermolysis bullosa. Efficacy 67% at 6 months. Learn mechanism of action and prospects.
